University of Surrey

Test tubes in the lab Research in the ATI Dance Research

Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC).

Gabitass, RF, Annels, NE, Crawshaw, J, Pandha, HS and Middleton, GW (2011) Use of gemcitabine- (Gem) and fluropyrimidine (FP)-based chemotherapy to reduce myeloid-derived suppressor cells (MDSCs) in pancreatic (PC) and esophagogastric cancer (EGC). JOURNAL OF CLINICAL ONCOLOGY, 29 (15).

Full text not available from this repository.
Item Type: Article
Authors :
NameEmailORCID
Gabitass, RFUNSPECIFIEDUNSPECIFIED
Annels, NEn.annels@surrey.ac.ukUNSPECIFIED
Crawshaw, JUNSPECIFIEDUNSPECIFIED
Pandha, HSh.pandha@surrey.ac.ukUNSPECIFIED
Middleton, GWUNSPECIFIEDUNSPECIFIED
Date : 20 May 2011
Uncontrolled Keywords : Science & Technology, Life Sciences & Biomedicine, Oncology
Related URLs :
Depositing User : Symplectic Elements
Date Deposited : 17 May 2017 10:13
Last Modified : 17 May 2017 14:48
URI: http://epubs.surrey.ac.uk/id/eprint/826908

Actions (login required)

View Item View Item

Downloads

Downloads per month over past year


Information about this web site

© The University of Surrey, Guildford, Surrey, GU2 7XH, United Kingdom.
+44 (0)1483 300800